Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyoji Okita

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Asian Journal of Psychiatry|July 24, 2024
Potential effect of ketamine in treatment for dextromethorphan use disorder exploding in Japanese young populationKaori Ishii, Kyoji Okita
The International Journal of Neuropsychopharmacology|September 17, 2016
Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine DependenceKyoji Okita, Mark A Mandelkern, Edythe D London
Annals of General Psychiatry|March 19, 2013
Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case seriesKyoji Okita, Akihiro Shiina, Michiko Nakazato, et al.
Neuropsychopharmacology Reports|April 16, 2024
Comparison of patients with benzodiazepine receptor agonist-related psychiatric disorders and over-the-counter drug-related psychiatric disorders before and after the COVID-19 pandemic: Changes in psychosocial characteristics and types of abused drugsTakashi Usami, Kyoji Okita, Takuya Shimane, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|December 25, 2025
Clinical characteristics and treatment resource utilization among patients with substance use disorders: A comparative study of individuals who misuse pharmaceuticals and use illegal drugsTakashi Usami, Toshihiko Matsumoto, Kyoji Okita, et al.
EJNMMI Research|December 14, 2021
Amyloid PET quantification using low-dose CT-guided anatomic standardizationHiroshi Matsuda, Tensho Yamao, Mitsuru Shakado, et al.
Frontiers in Neuroscience|September 30, 2021
Effects of an Adenosine A<sub>2A</sub> Receptor Antagonist on Striatal Dopamine D2-Type Receptor Availability: A Randomized Control Study Using Positron Emission TomographyKyoji Okita, Koichi Kato, Yoko Shigemoto, et al.
Neuropsychopharmacology Reports|September 20, 2025
Clinical Characteristics of Patients With Cannabis-Related Mental Disorders and an Examination of Factors Influencing Their Access to Medical and Nonmedical Resources: Comparison of Methamphetamine-Related Mental DisordersToshihiko Matsumoto, Takashi Usami, Akiho Nishimura, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|December 18, 2025
Deliberate self-harm in adolescents with OTC-related psychiatric disorders: A study of prevalence and associated factorsToshihiko Matsumoto, Takashi Usami, Akiho Nishimura, et al.
The International Journal of Neuropsychopharmacology|February 13, 2019
Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor AvailabilityTodd Zorick, Kyoji Okita, Mark A Mandelkern, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Asian Journal of Psychiatry|July 24, 2024
Potential effect of ketamine in treatment for dextromethorphan use disorder exploding in Japanese young populationKaori Ishii, Kyoji Okita
The International Journal of Neuropsychopharmacology|September 17, 2016
Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine DependenceKyoji Okita, Mark A Mandelkern, Edythe D London
Annals of General Psychiatry|March 19, 2013
Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case seriesKyoji Okita, Akihiro Shiina, Michiko Nakazato, et al.
Neuropsychopharmacology Reports|April 16, 2024
Comparison of patients with benzodiazepine receptor agonist-related psychiatric disorders and over-the-counter drug-related psychiatric disorders before and after the COVID-19 pandemic: Changes in psychosocial characteristics and types of abused drugsTakashi Usami, Kyoji Okita, Takuya Shimane, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|December 25, 2025
Clinical characteristics and treatment resource utilization among patients with substance use disorders: A comparative study of individuals who misuse pharmaceuticals and use illegal drugsTakashi Usami, Toshihiko Matsumoto, Kyoji Okita, et al.
EJNMMI Research|December 14, 2021
Amyloid PET quantification using low-dose CT-guided anatomic standardizationHiroshi Matsuda, Tensho Yamao, Mitsuru Shakado, et al.
Frontiers in Neuroscience|September 30, 2021
Effects of an Adenosine A<sub>2A</sub> Receptor Antagonist on Striatal Dopamine D2-Type Receptor Availability: A Randomized Control Study Using Positron Emission TomographyKyoji Okita, Koichi Kato, Yoko Shigemoto, et al.
Neuropsychopharmacology Reports|September 20, 2025
Clinical Characteristics of Patients With Cannabis-Related Mental Disorders and an Examination of Factors Influencing Their Access to Medical and Nonmedical Resources: Comparison of Methamphetamine-Related Mental DisordersToshihiko Matsumoto, Takashi Usami, Akiho Nishimura, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|December 18, 2025
Deliberate self-harm in adolescents with OTC-related psychiatric disorders: A study of prevalence and associated factorsToshihiko Matsumoto, Takashi Usami, Akiho Nishimura, et al.
The International Journal of Neuropsychopharmacology|February 13, 2019
Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor AvailabilityTodd Zorick, Kyoji Okita, Mark A Mandelkern, et al.
Pageof 4